89 related articles for article (PubMed ID: 8183246)
1. Kinetics of inhibition by tyrphostins of the tyrosine kinase activity of the epidermal growth factor receptor and analysis by a new computer program.
Posner I; Engel M; Gazit A; Levitzki A
Mol Pharmacol; 1994 Apr; 45(4):673-83. PubMed ID: 8183246
[TBL] [Abstract][Full Text] [Related]
2. The degree of inhibition of protein tyrosine kinase activity by tyrphostin 23 and 25 is related to their instability.
Ramdas L; McMurray JS; Budde RJ
Cancer Res; 1994 Feb; 54(4):867-9. PubMed ID: 7508821
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
Lipson KE; Pang L; Huber LJ; Chen H; Tsai JM; Hirth P; Gazit A; Levitzki A; McMahon G
J Pharmacol Exp Ther; 1998 May; 285(2):844-52. PubMed ID: 9580635
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antiproliferative activity of tyrphostins containing heteroaromatic moieties.
Brunton VG; Lear MJ; Robins DJ; Williamson S; Workman P
Anticancer Drug Des; 1994 Aug; 9(4):291-309. PubMed ID: 7916898
[TBL] [Abstract][Full Text] [Related]
5. Antiproliferative effect of tyrosine kinase inhibitors in epidermal growth factor-stimulated growth of human gastric cancer cells.
Piontek M; Hengels KJ; Porschen R; Strohmeyer G
Anticancer Res; 1993; 13(6A):2119-23. PubMed ID: 8297123
[TBL] [Abstract][Full Text] [Related]
6. Activation of the epidermal growth factor receptor by skin tumor promoters and in skin tumors from SENCAR mice.
Xian W; Kiguchi K; Imamoto A; Rupp T; Zilberstein A; DiGiovanni J
Cell Growth Differ; 1995 Nov; 6(11):1447-55. PubMed ID: 8562483
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative effects of tyrosine kinase inhibitors (tyrphostins) on human bladder and renal carcinoma cells.
Sion-Vardy N; Vardy D; Rodeck U; Kari C; Levin RM; Malkowicz SB
J Surg Res; 1995 Dec; 59(6):675-80. PubMed ID: 8538164
[TBL] [Abstract][Full Text] [Related]
8. Receptor-guided alignment-based comparative 3D-QSAR studies of benzylidene malonitrile tyrphostins as EGFR and HER-2 kinase inhibitors.
Kamath S; Buolamwini JK
J Med Chem; 2003 Oct; 46(22):4657-68. PubMed ID: 14561085
[TBL] [Abstract][Full Text] [Related]
9. Receptor tyrosine kinase inhibition suppresses growth of pediatric renal tumor cells in vitro.
Naraghi S; Khoshyomn S; DeMattia JA; Vane DW
J Pediatr Surg; 2000 Jun; 35(6):884-90. PubMed ID: 10873031
[TBL] [Abstract][Full Text] [Related]
10. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation.
Schmidt-Ullrich RK; Mikkelsen RB; Dent P; Todd DG; Valerie K; Kavanagh BD; Contessa JN; Rorrer WK; Chen PB
Oncogene; 1997 Sep; 15(10):1191-7. PubMed ID: 9294612
[TBL] [Abstract][Full Text] [Related]
11. Protein binding modulates inhibition of the epidermal growth factor receptor kinase and DNA synthesis by tyrphostins.
Hoffman R; Dennis IF; Donaldson J
Cancer Chemother Pharmacol; 1995; 36(4):316-24. PubMed ID: 7628051
[TBL] [Abstract][Full Text] [Related]
12. Tyrphostins. 6. Dimeric benzylidenemalononitrile tyrophostins: potent inhibitors of EGF receptor tyrosine kinase in vitro.
Gazit A; Osherov N; Gilon C; Levitzki A
J Med Chem; 1996 Dec; 39(25):4905-11. PubMed ID: 8960549
[TBL] [Abstract][Full Text] [Related]
13. Tyrphostin induces non-apoptotic programmed cell death in colon tumor cells.
Szende B; Kéri G; Szegedi Z; Benedeczky I; Csikós A; Orfi L; Gazit A
Cell Biol Int; 1995 Nov; 19(11):903-11. PubMed ID: 8574217
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of novel tyrosine kinase inhibitors using a pharmacophore model of the ATP-binding site of the EGF-R.
Traxler P; Furet P; Mett H; Buchdunger E; Meyer T; Lydon N
J Pharm Belg; 1997; 52(2):88-96. PubMed ID: 9193132
[TBL] [Abstract][Full Text] [Related]
15. Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity of receptors for the EGF family of growth factors.
Rewcastle GW; Murray DK; Elliott WL; Fry DW; Howard CT; Nelson JM; Roberts BJ; Vincent PW; Showalter HD; Winters RT; Denny WA
J Med Chem; 1998 Feb; 41(5):742-51. PubMed ID: 9513602
[TBL] [Abstract][Full Text] [Related]
16. Kinetic model of the epidermal growth factor (EGF) receptor tyrosine kinase and a possible mechanism of its activation by EGF.
Posner I; Engel M; Levitzki A
J Biol Chem; 1992 Oct; 267(29):20638-47. PubMed ID: 1328205
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor system is a physiological regulator of development of the mouse fetal submandibular gland and regulates expression of the alpha6-integrin subunit.
Kashimata M; Gresik EW
Dev Dyn; 1997 Feb; 208(2):149-61. PubMed ID: 9022052
[TBL] [Abstract][Full Text] [Related]
18. Activation of epidermal growth factor receptor during corneal epithelial migration.
Zieske JD; Takahashi H; Hutcheon AE; Dalbone AC
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1346-55. PubMed ID: 10798649
[TBL] [Abstract][Full Text] [Related]
19. Rieger syndrome revisited: experimental approaches using pharmacologic and antisense strategies to abrogate EGF and TGF-alpha functions resulting in dysmorphogenesis during embryonic mouse craniofacial morphogenesis.
Slavkin HC
Am J Med Genet; 1993 Oct; 47(5):689-97; discussion 687-8. PubMed ID: 8266997
[TBL] [Abstract][Full Text] [Related]
20. Tannic acid, a potent inhibitor of epidermal growth factor receptor tyrosine kinase.
Yang EB; Wei L; Zhang K; Chen YZ; Chen WN
J Biochem; 2006 Mar; 139(3):495-502. PubMed ID: 16567414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]